I-4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory

Inkcazelo emfutshane:

Igama leKhemikhali: 4-Aminopyridine

CAS: 504-24-5

Uvavanyo: ≥99.5% (HPLC)

Imbonakalo: Umgubo weCrystalline oMhlophe okanye oMthubi kancinane

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi, ubunyulu obuphezulu, iMveliso yoRhwebo
Igama leKhemikhali: 4-Aminopyridine
CAS: 504-24-5

Iipropati zeMichiza:

Igama leMchiza 4-Aminopyridine
Izithethantonye 4-AP;I-4-Pyridinamine;iFampridine;I-Dalfampridine;p-Aminopyridine;γ-Aminopyridine
Inombolo yeCAS 504-24-5
Inombolo yeCAT RF-PI539
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli I-C5H6N2
Ubunzima beMolekyuli 94.12
Ukunyibilika Inyibilika emanzini, i-Ethanol
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Umgubo weCrystalline oMhlophe okanye oMthubi kancinane
Indlela yoVavanyo / yoHlahlelo ≥99.5% (HPLC)
Indawo yokunyibilika 157.0 ~ 162.0℃
Amanzi (KF) ≤0.50%
Uthuthu lweSulfate ≤0.20%
2-Aminopyridine ≤0.10%
3-Aminopyridine ≤0.10%
Ukungcola ngokupheleleyo ≤0.50%
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa abaPhakathi bamayeza;API

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-4-Aminopyridine (i-CAS: 504-24-5) yenye yee-amine ezintathu ze-isomeri ze-pyridine, i-compound ecocekileyo kakhulu, eyokwenziwa, kunye ne-biologically esebenzayo, esetyenziswa ngokubanzi kwi-organic synthesis, i-synthesis ye-pharmaceutical intermediates kunye ne-Active Pharmaceutical Ingredient (API). ) ukuhlanganiswa.I-4-Aminopyridine (i-4-AP, i-Fampridine, i-Dalfampridine) isetyenziswe njengesixhobo sophando ekuboniseni i-subtypes ye-channel ye-potassium.Kwakhona isetyenziswe njengeziyobisi, ukulawula ezinye zeempawu ze-multiple sclerosis, kwaye ibonakaliswe ukuphuculwa kweempawu zokuhamba kubantu abadala abaneenguqu ezininzi zesifo.I-US Food and Drug Administration (FDA) ivume ikhompawundi ngoJanuwari 22, 2010. I-Fampridine iphinda ithengiswe e-United States yi-Acorda Therapeutics kunye ne-Fampyra kwi-European Union, eCanada, nase-Australia.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi